Back

Immune-related constrictive pericarditis induced by pembrolizumab: a clinical challenge in managing inflammation and heart failure

11 May 2026 (14:03 - 14:15)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology emergencies: immune checkpoint inhibitor myo-pericarditis, failure, and shock Cardio-Oncology Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mr Gerard Torres Padilla

Hospital del Mar, Barcelona (Spain)

3 More presentations in this session

Presentation thumbnail
Immune-mediated myocarditis in a patient with metastatic endometrial carcinoma: diagnostic and therapeutic challenges
Doctor M. Pereira Santos (Porto, PT)
Slides Video
Presentation thumbnail
When the heart is affected while fighting cancer: immune checkpoint inhibitor–associated myocarditis
Doctor G. Ozdogan (Istanbul, TR) Doctor S. Kilic (Istanbul, TR)
Slides Video
Presentation thumbnail
Fulminant immune checkpoint inhibitor related myo-pericarditis complicated by biventricular failure presenting with cardiac tamponade and cardiogenic shock: a clinical case
Doctor T. Nikiforou (Rozzano, IT)
Slides Video

Access the full session

Session thumbnail
Cardio-oncology emergencies: immune checkpoint inhibitor myo-pericarditis, failure, and shock
Video

The Event

Event poster

Heart Failure 2026

11 May 2026 14:03 CET
You may be interested in
thumbnail
Congress Session
Cardio-oncology emergencies: immune checkpoint inhibitor myo-pericarditis, failure, and shock
thumbnail
Congress Presentation
An immune checkpoint inhibitor-related effusive-constrictive pericarditis as a part of a wide range multi-organ immune-related phenomena
thumbnail
Congress Presentation
Fulminant immune checkpoint inhibitor related myo-pericarditis complicated by biventricular failure presenting with cardiac tamponade and cardiogenic shock: a clinical case

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources